⌘+K

Pulse Explore Clubs Researchers Journals

Home Clubs Explore

November 22, 2016Biochimica et Biophysica Acta (BBA) - Molecular Cell ResearchOpen Access

Cardiac inositol 1,4,5-trisphosphate receptors

View Full Paper

Ask AI

Bookmark

Share

Design

Review

Authors

MGM. Iveth GarciaUnited States Food and Drug Administration DBDarren BoehningCooper Medical School of Rowan University

Discussion

Loading...

Member takes

Implication

IP3R targeting may attenuate hypertrophy; leaves open clinical translation in human disease.

Key Points

Key points are not available for this paper at this time.

Cite This Study

Garcia et al. (2016) studied this question.

synapsesocial.com/papers/6a8077e47a38d5ff71e45af2 https://doi.org/10.1016/j.bbamcr.2016.11.017

View Full Paper

Ask AI

Bookmark

Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Endothelin-1-Stimulated InsP3-Induced Ca2+ Release Is a Nexus for Hypertrophic Signaling in Cardiac Myocytes2009 · 148 citations
2No Contribution of IP <sub>3</sub> -R(2) to Disease Phenotype in Models of Dilated Cardiomyopathy or Pressure Overload Hypertrophy2012 · 19 citations
3Phosphorylation of the Inositol 1,4,5-Trisphosphate Receptor1996 · 213 citations
4The BRCA1 Tumor Suppressor Binds to Inositol 1,4,5-Trisphosphate Receptors to Stimulate Apoptotic Calcium Release2015 · 78 citations
5Selective Upregulation of Cardiac Endothelin System in Patients With Ischemic but Not Idiopathic Dilated Cardiomyopathy2000 · 92 citations